Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 117.97%47.9M | ---- | 51.42%-266.58M | ---- | -49.18%-548.71M | ---- | -27.19%-367.81M | ---- | -17.21%-289.17M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -159.21%-18.01M | ---- | ---6.95M | ---- | ---- | ---- | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | -70.21%7.06M | ---- | 13.47%23.7M | ---- | 284.43%20.89M | ---- | --5.43M | ---- | ---- |
| Impairment and provisions: | ---- | ---- | ---- | 1,062.59%39.01M | ---- | -59.25%3.36M | ---- | 437.56%8.23M | ---- | -117.46%-2.44M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | --13.52M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | -57.06%1.41M | ---- | -59.17%3.27M | ---- | 411.26%8.02M | ---- | -132.47%-2.58M |
| -Impairment of goodwill | ---- | ---- | ---- | --20.26M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | 4,618.52%3.82M | ---- | -62.33%81K | ---- | 56.93%215K | ---- | -97.73%137K |
| Revaluation surplus: | ---- | -155.13%-18.39M | ---- | 250.80%33.36M | ---- | -294.85%-22.12M | ---- | 277.97%11.35M | ---- | -957.16%-6.38M |
| -Other fair value changes | ---- | -155.13%-18.39M | ---- | 250.80%33.36M | ---- | -294.85%-22.12M | ---- | 277.97%11.35M | ---- | -957.16%-6.38M |
| Asset sale loss (gain): | ---- | 119.81%1.89M | ---- | -606.25%-9.56M | ---- | 660.24%1.89M | ---- | -260.48%-337K | ---- | -53.31%210K |
| -Loss (gain) from sale of subsidiary company | ---- | 119.83%1.89M | ---- | ---9.51M | ---- | ---- | ---- | ---- | ---- | --25K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 115.09%8K | ---- | -102.81%-53K | ---- | 660.24%1.89M | ---- | -282.16%-337K | ---- | -58.87%185K |
| Depreciation and amortization: | ---- | -58.06%24.51M | ---- | -3.80%58.43M | ---- | -2.43%60.74M | ---- | 4.43%62.25M | ---- | 4.95%59.61M |
| -Amortization of intangible assets | ---- | -38.41%8.9M | ---- | -2.07%14.45M | ---- | 0.07%14.76M | ---- | 21.66%14.75M | ---- | 47.89%12.12M |
| Financial expense | ---- | -79.03%2.93M | ---- | -37.63%13.96M | ---- | -34.94%22.39M | ---- | -30.17%34.41M | ---- | -21.11%49.28M |
| Special items | ---- | -448.48%-7.32M | ---- | -89.12%2.1M | ---- | -85.49%19.29M | ---- | -29.52%132.98M | ---- | 650.99%188.68M |
| Operating profit before the change of operating capital | ---- | 136.06%40.57M | ---- | 74.56%-112.53M | ---- | -289.73%-442.29M | ---- | -53,179.34%-113.49M | ---- | 99.76%-213K |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | -112.40%-2.16M | ---- | -81.93%17.42M | ---- | 190.98%96.38M | ---- | -583.62%-105.93M | ---- | 173.19%21.9M |
| Accounts payable increase (decrease) | ---- | 79.75%-128.83M | ---- | -320.59%-636.05M | ---- | 208.25%288.34M | ---- | 70.13%93.54M | ---- | 222.26%54.98M |
| prepayments (increase)decrease | ---- | -15.89%6.88M | ---- | 474.51%8.18M | ---- | -7.53%-2.19M | ---- | 4.42%-2.03M | ---- | -157.70%-2.13M |
| Special items for working capital changes | ---- | -692.48%-234.91M | ---- | -83.20%39.65M | ---- | 183.49%235.99M | ---- | -171.07%-282.67M | ---- | -551.90%-104.28M |
| Cash from business operations | 18.41%-158.9M | 53.40%-318.44M | 61.32%-194.74M | -487.74%-683.33M | -689.46%-503.5M | 142.92%176.24M | -83.96%85.42M | -1,280.82%-410.57M | 390.72%532.63M | 84.76%-29.73M |
| Other taxs | 91.11%-12K | 57.20%-1.32M | 93.20%-135K | 40.46%-3.08M | 54.46%-1.99M | -8.44%-5.17M | -36.41%-4.36M | -243.90%-4.76M | -74.32%-3.2M | -4.85%-1.39M |
| Net cash from operations | 18.46%-158.91M | 53.42%-319.76M | 61.45%-194.88M | -501.24%-686.4M | -723.63%-505.48M | 141.19%171.07M | -84.69%81.06M | -1,234.67%-415.34M | 396.16%529.43M | 84.16%-31.12M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -70.08%2.98M | 190.95%17.2M | 409.78%9.96M | 366.61%5.91M | 459.60%1.95M | 124.25%1.27M | 64.62%349K | -15.80%565K | -11.30%212K | 40.97%671K |
| Restricted cash (increase) decrease | --149K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | 200.30%20.27M | --5.48M | ---20.21M | ---- | ---- |
| Sale of fixed assets | 186.96%66K | -73.03%106K | -89.69%23K | -95.63%393K | --223K | 1,797.89%9M | ---- | 194.41%474K | ---- | 58.62%161K |
| Purchase of fixed assets | -3,787.77%-8.9M | ---3.05M | ---229K | ---- | ---- | 85.37%-1.84M | 84.83%-1.69M | -289.98%-12.57M | -572.86%-11.16M | 79.31%-3.22M |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -505.76%-34.08M | ---- | 45.71%-5.63M |
| Sale of subsidiaries | ---- | ---9.43M | ---6.41M | ---- | ---- | --32K | ---- | ---- | ---- | ---135K |
| Acquisition of subsidiaries | ---1.51M | ---1.63M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | ---3.9M | ---- | ---- | ---- | ---- | 64.24%-13.77M | ---- | ---38.5M | ---38.51M | ---- |
| Net cash from investment operations | -432.48%-11.12M | -49.41%3.19M | 53.68%3.34M | -57.86%6.31M | -47.41%2.18M | 114.34%14.96M | 108.37%4.14M | -1,179.88%-104.32M | -616.76%-49.45M | 67.86%-8.15M |
| Net cash before financing | 11.23%-170.03M | 53.45%-316.57M | 61.94%-191.54M | -465.58%-680.1M | -690.78%-503.31M | 135.80%186.03M | -82.25%85.19M | -1,223.30%-519.66M | 380.91%479.98M | 82.30%-39.27M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -54.59%210.01M |
| Refund | ---- | ---- | ---- | 67.06%-21.2M | ---- | 51.39%-64.35M | ---- | 32.67%-132.38M | -11.22%-124.32M | 31.09%-196.62M |
| Issuing shares | ---- | --714.16M | --714.16M | ---- | ---- | ---- | ---- | 330.10%1.25B | 336.28%1.22B | 2,172.77%290.89M |
| Interest paid - financing | 73.86%-497K | 87.86%-1.73M | 84.75%-1.9M | 32.35%-14.28M | -15.92%-12.46M | 9.88%-21.11M | 39.16%-10.75M | 36.39%-23.43M | 12.67%-17.67M | -5.36%-36.83M |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---1.82M | ---- | ---- | ---1.36M | ---1.35M | ---- |
| Net cash from financing operations | -100.92%-6.49M | 959.80%695.9M | 2,016.24%702.02M | 34.99%-80.94M | -51.19%-36.64M | -111.78%-124.5M | -102.29%-24.23M | 349.73%1.06B | 426.50%1.06B | 91.11%234.98M |
| Effect of rate | -63.76%469K | 6.45%4.03M | -24.81%1.29M | 154.81%3.78M | -57.49%1.72M | -276.47%-6.9M | 361.57%4.05M | 24.21%3.91M | 224.75%877K | 178.84%3.15M |
| Net Cash | -134.58%-176.52M | 149.84%379.33M | 194.54%510.48M | -1,336.69%-761.04M | -985.70%-539.94M | -88.54%61.54M | -96.04%60.96M | 174.44%537.12M | 411.39%1.54B | 297.95%195.71M |
| Begining period cash | 152.19%635.26M | -75.04%251.9M | -75.04%251.9M | 5.72%1.01B | 5.72%1.01B | 130.85%954.52M | 130.85%954.52M | 92.66%413.49M | 92.66%413.49M | -27.21%214.63M |
| Cash at the end | -39.87%459.21M | 152.19%635.26M | 62.16%763.68M | -75.04%251.9M | -53.81%470.94M | 5.72%1.01B | -47.82%1.02B | 130.85%954.52M | 279.41%1.95B | 115.39%413.49M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.